Pathogenesis and therapy of non-oliguric hyperkalaemia of the premature infant

European Journal of Pediatrics

Volumn 161, Issue 8, 2002, Pages 415-422

  Mildenberger, Eva ^a   Versmold, Hans T ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Non oliguric hyperkalaemia; Premature infant; Salbutamol

Indexed keywords

BICARBONATE; CALCIUM; DIURETIC AGENT; FUROSEMIDE; GLUCOSE; INSULIN; ION EXCHANGE RESIN; POTASSIUM; SALBUTAMOL;

ARRHYTHMOGENESIS; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; EXCHANGE BLOOD TRANSFUSION; EXTRACELLULAR SPACE; HUMAN; HYPERKALEMIA; PATHOGENESIS; PERITONEAL DIALYSIS; POTASSIUM BLOOD LEVEL; POTASSIUM EXCRETION; PREMATURITY; PRIORITY JOURNAL; REVIEW;

ADRENERGIC BETA-AGONISTS; ALBUTEROL; CALCIUM; DIURETICS; EVIDENCE-BASED MEDICINE; EXCHANGE TRANSFUSION, WHOLE BLOOD; GLUCOSE; HUMANS; HYPERKALEMIA; HYPOGLYCEMIC AGENTS; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; INSULIN; NEONATOLOGY; PERITONEAL DIALYSIS; PRACTICE GUIDELINES; RISK FACTORS; SAFETY; SODIUM BICARBONATE; TREATMENT OUTCOME;

EID: 0036353161     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-002-0986-9     Document Type: Review

References (69)

1. Drugs and the kidney
2. Sodium homeostasis in term and preterm neonates. I Renal aspects
3. Effect of bicarbonate administration on plasma potassium in dialysis patients: Interactions with insulin and albuterol
4. + ATPase activity in neonatal and adult red blood cells
5. Sodium excretion in relation to sodium intake and aldosterone excretion in newborn pre-term and full-term infants
6. Postnatal control of water and electrolyte homeostasis in pre-term and full-term infants
7. Postnatale hyperkaliämie sehr kleiner frühgeborener
8. Cecal perforation associated with sodium polystyrene sulfonate-sorbitol enemas in a 650 gram infant with hyperkalemia
9. Extrarenal potassium homeostasis
10. Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure
11. Early hyperkalaemia in very low birthweight infants in the absence of oliguria
12. Kidney and urinary tract
13. What are normal potassium concentrations in the neonate? What is a reasonable approach to hyperkalemia in the newborn with normal renal function?
14. Alkali therapy for neonates: Where does it stand today?
15. Salbutamol in the treatment of neonatal hyperkalemia
16. The dose-related hyper- and hypokalaemic effects of salbutamol and its arrhythmogenic potential
17. Factors causing hyperkalemia in premature infants
18. Attenuated response to insulin in very low birth-weight infants
19. Salbutamol infusion to treat neonatal hyperkalaemia
20. Nonoliguric hyperkalemia in the premature infant weighing less than 1000 grams
21. Aggressive, early insulin and glucose treatment for hyperkalaemia in extremely low gestation newborns
22. Glucose and insulin infusion versus kayexalate for the early treatment of non-oliguric hyperkalemia in very-low-birth-weight infants
23. Disorders of carbohydrate metabolism
24. Alkalinization is ineffective for severe hyperkalemia in non-nephronectomized dogs
25. Morbidity and mortality associated with exchange transfusion
26. Effective treatment of acute hyperkalaemia in childhood by short-term infusion of salbutamol
27. Early onset hyperkalemia in extremely low birth weight infants
28. Acute therapy for hyperkalemia with the combined regimen of bicarbonate and beta(2)-adrenergic agonist (salbutamol) in chronic renal failure patients
29. The emergency treatment of hyperkalemia
30. + metabolism
31. Treatment of hyperkalaemia in renal failure: Salbutamol v. insulin
32. Early neonatal hyperkalaemia in the extremely premature newborn infant
33. Hypokalemic effects of intravenous infusion or nebulization of salbutamol in patients with chronic renal failure: Comparative study
34. Treatment of hyperkalemia with exchange transfusion
35. Nonoliguric hyperkalemia in preterm neonates
36. Potassium metabolism in extremly low birth weight infants in the first week of life
37. Treatment with hypertonic dextrose and insulin in severe hyperkalaemia of immature infants
38. Glucose and insulin versus cation-exchange resin for the treatment of hyperkalemia in very low birth weight infants
39. Salbutamol metered-dose inhaler with spacer for hyperkalemia. How fast? How safe?
40. Treatment of hyperkalaemia using intravenous and nebulised salbutamol
41. Postnatal hyperkalemia of the very low birthweight infant: A trait of immaturity
42. Results of a national survey in Germany on incidence and therapy of the nonoliguric hyperkalemia of the premature infant
43. Successful peritoneal dialysis in a premature infant with a birth weight of 850 grams - A case report
44. Treatment of hyperkalaemia with intravenous salbutamol
45. Hyperkalemia and hypokalemia
46. Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: Effects of various therapeutic approaches
47. Treatment of hyperkalemia in children with intravenous salbutamol
48. Complications following oral administration of exchange resins in extremely low-birth-weight infants
49. Effect of prenatal steroids on potassium balance in extremely low birthweight neonates
50. Common fluid and electrolyte problems in the pediatric intensive care unit
51. Neontal hyperkalemia
52. Adrenergic modulation of extrarenal potassium disposal
53. Sodium and potassium in red blood cells of premature infants during the first few days: Risk of hyperkalemia
54. Internal potassium shift in premature infants: Cause of nonoliguric hyperkalemia
55. Potassium-related cardiac arrhythmias and their treatment
56. A warning for the treatment of hyperkalaemia with salbutamol
57. Renal insufficiency and acute renal failure
58. Exchange transfusion using washed red blood cells reconstituted with fresh-frozen plasma for treatment of severe hyperkalemia in the neonate
59. Hyperkalemia in very low birth weight infants
60. Hyperkalaemia, cardiac arrhythmias, and cerebral lesions in high risk neonates
61. + -ATPase activity associated with cellular potassium loss in extremely low birth weight infants with nonoliguric hyperkalemia
62. Hyperkalemia - A critical complication of hypoxic premature infants
63. Possible pathogenetic factors in neonatal hypocalcemia of prematurity
64. The respiratory distress syndrome of prematurity. I. Changes in potassium in the serum and the electrocardiogram and effects of therapy
65. Treatment of attacks in hyperkalaemic familial periodic paralysis by inhalation of salbutamol
66. Plasma potassium response after tromethamine (THAM) or sodium bicarbonate in the acidotic rabbit
67. The mechanism of salbutamol-induced hypokalaemia